Published in IJCP April 2019
Clinical Study
A Prospective Study to Evaluate the Effectiveness of Negative-pressure Wound Therapy for Management of Acute Traumatic and Chronic Wound in Orthopedics
April 10, 2019 | Ram Avtar, Ravikant Jain
     


Abstract

Introduction: Acute and chronic wounds affect at least 1% of the population. Regardless of etiology, wounds are difficult to treat. Modern wound healing concepts have convincingly been shown to give higher wound closure rates compared with traditional wet gauze dressings. Objectives: To evaluate the results and benefits obtained from the use of negative-pressure wound therapy (NPWT) in patients with acute and chronic wounds in orthopedics. Material and methods: This was a prospective study of 26 patients (16 males and 10 females, mean age 41.76 years) with acute and chronic wounds treated using NPWT. The acute wounds were caused by trauma (road traffic accident [RTA], fall from height, crush injury). The chronic wounds stated in this study were from pressure sores in paraplegic patients. The treatment system used was VAC (vacuum-assisted closure, KCI, San Antonio, United States), applied to the wound in continuous mode from 100 to 125 mmHg. Results: The mean length of the use of NPWT was 20 days. The use of VAC led to a mean reduction of 37% in the wound area (157.12-120.57 cm2; p < 0.05). Exposed tendons and bone were successfully covered with healthy granulation tissue in all cases. In all patients, coverage with granulation tissue was achieved and followed by a skin graft. No major complication occurred that was directly attributable to the treatment. Conclusion: NPWT eases the process of wound healing by formation of local infection free healing tissue in a short period of time and reduces hospital stay and morbidity.

Keywords: Negative-pressure wound therapy, wound healing, wounds and injuries, pressure sore

Dealing with wound is a matter of knowledge and experience. Different etiologies such as trauma and infection may lead to acute and chronic wounds. Regardless of etiology, wounds are difficult to treat if co-existing factors (e.g., infection or diabetes mellitus) prevent regular wound healing. Wounds represent a significant risk factor for hospitalization, amputation, sepsis and even death, and from the patient’s perspective, wound therapy is often uncomfortable or painful. Modern wound healing concepts include different types of moist dressings and topical agents, although only a few of these treatments have convincingly been shown to give higher wound closure rates compared with traditional wet gauze dressings. Negative-pressure wound therapy (NPWT) is a newer noninvasive adjunctive therapy system that uses controlled negative-pressure, using vacuum-assisted closure (VAC) device, to help promote wound healing by removing fluid from open wounds, preparing the wound bed for closure, reducing edema and promoting formation and perfusion of granulation tissue.

Negative-pressure wound therapy, also known as VAC dressing, provides the following benefits: control of drainage of fluids, reduction of local edema, reduction of bacterial load and early development of granulation tissue by angiogenic stimulation. The aim of the present study is to evaluate the effect of NPWT in management of acute and chronic wounds in the orthopedic set-up.

Material and Methods

The present study was undertaken at ESI Hospital, Basai Darapur, New Delhi, India. Over a 1 year period, from July 2017 to July 2018, 26 patients (16 males and 10 females; Table 1) with acute and chronic wounds were treated with NPWT device (VAC, KCI, San Antonio, United States).

Table 1. Patients Demographic Data

Sex

Number

Percentage (%)

Male

16

61.53

Female

10

38.46

The following inclusion criteria were adopted: Presence of positive culture, use of vacuum drainage for over 5 days, purulent local drainage and tissue necrosis.

Patient exclusion criteria included: Small-sized acute wounds with no comorbid conditions, age less than 15 years, mental disorders, systemic sepsis, malignancy and osteomyelitis.

All 26 patients were followed for minimum 6 months (mean 11 months, range: 6-18 months). Mean patient age was 41.76 years (range: 16-67 years). In all acute wounds, VAC was used when granulation tissue started to appear. In regard to chronic wounds, the lesion was debrided to refresh the bed and the edges before application of VAC. On average, wound was assessed every 4th day in term of the size, the defect and evolution of state of the wound. Final procedure after VAC therapy and complications related to the use of this therapy were evaluated. Patients were followed-up regularly in the OPD with minimum follow-up period of 6 months.

Results

In the present study, 26 patients (16 males and 10 females) with mean age 41.76 years (16-67 years) were included. Out of the 26 patients, 20 patients had acute post-traumatic wound and 6 patients were having chronic wound. All patients were given a mean of 12 days of intravenous antibiotic therapy (8-42 days). The median duration of VAC therapy was 20 days (5-50); on average, the dressing was changed every 4th day.

A 37% mean reduction of wound area was observed, from 157.12 cm2 to 120.57 cm2  after VAC application. In all patients, coverage with granulation tissue was achieved and followed by a skin graft. Table 2 summarizes the results of VAC therapy.

Table 2. Reults of VAC Therapy

Age

Area before VAC

Area after VAC

Days

VAC exchange

Procedure

16

25

18

10

3

Skin grafting

46

300

220

46

12

Skin grafting

25

12

5

12

3

Skin grafting

46

170

128

30

7

Skin grafting

36

89

76

36

10

Skin grafting

30

65

44

16

4

Skin grafting

32

68

49

16

4

Skin grafting

49

100

70

25

6

Skin grafting

53

129

119

20

5

Skin grafting

39

96

50

25

6

Skin grafting

58

10

7

22

5

Skin grafting

67

46

40

20

6

Skin grafting

39

280

130

25

4

Skin grafting

25

320

260

16

5

Skin grafting

32

26

22

20

5

Skin grafting

29

10

6

5

2

Skin grafting

60

128

96

30

5

Skin grafting

35

125

94

26

5

Skin grafting

62

430

310

50

12

Skin grafting

59

16

12

16

4

Skin grafting

39

280

264

18

5

Skin grafting

43

87

55

19

5

Skin grafting

49

432

380

30

6

Skin grafting

46

360

260

18

5

Skin grafting

39

320

255

18

5

Skin grafting

35

160

120

16

4

Skin grafting

Almost all patients achieved an improvement in the final appearance of the wound site, with infection eradication. No complications that could be directly attributed to the use of NPWT, such as deep bleeding or worsening local infection, were observed. Three patients had mild local itching, which was successfully treated with oral medication, allowing for the maintenance of treatment.

Figures 1-3 depict the wound before VAC, after VAC and after skin grafting, respectively. Figures 4 and 5 also depict a wound before and after VAC.

Figure 1. Wound before VAC.

Figure 2. Wound after VAC.

Figure 3. Wound after skin grafting.

Figure 4. Wound before VAC.

Figure 5. Wound after VAC.

Discussion

Numerous papers have been published on VAC therapy, which suggest that the technique may have an important role to play in the management of chronic or infected wound. The topical use of NPWT has been widely studied in the literature over the past 20 years. A vast majority of clinical trials has shown the effectiveness of this therapy in the treatment of superficial wounds.  The localized use of NPWT in infected wounds offers advantages such as wound drainage, angiogenesis stimulation, proteinase excretion and decreased local and systemic bacterial load.

In the present study, the mean time of VAC use was 20 days and the mean duration of intravenous antibiotic therapy was 12 days, in contrast with data in the literature indicating the use of intravenous antibiotics for 6 weeks for patients with infected wounds. In this treatment period, the dressing was changed every 4th day, providing comfort to the patient and the nursing staff, while maintaining a clean dressing without the need for daily changes.

In the present study, healthy infection-free granulation tissue was obtained in all patients, alongside a significant decrease in lesion size. These data are similar to those obtained by Gregor et al, who, in a systematic review to assess the effectiveness and safety of VAC compared to conventional therapies for complex wounds, observed a significant reduction of the lesion area for those treated with VAC, without significant adverse effects. In the present study, there were no major complications, such as hemorrhage, etc.

Conclusion

NPWT therapy adheres to DeBakey’s principles of being short, safe and simple. The VAC system eases the process of wound healing in chronic and acute wounds with reduction in morbidity and hospital stay. NPWT facilitates the formation of a local infection-free healing tissue in a short period of time, which reduces the need for complex surgical procedures for the final coverage of important structures. From this present study, it is concluded that NPWT is a safe, effective and fast alternative to conventional dressing in the treatment of acute and chronic wounds. There is no significant complication associated with the use of NPWT. The main limitation of the present study, apart from the small sample size, was the lack of a control group, which did not allow for a direct comparison of patients treated in the same center with conventional method or NPWT. Future studies with large sample size and control group are needed to accurately assess the benefit of VAC therapy.

Suggested Reading

  1. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38(6):553-62.
  2. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38(6):563-76; discussion 577.
  3. Saxena V, Hwang CW, Huang S, Eichbaum Q, Ingber D, Orgill DP. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg. 2004;114(5):1086-96; discussion 1097-8.
  4. Ramanujam CL, Stapleton JJ, Zgonis T. Negative-pressure wound therapy in the management of diabetic Charcot foot and ankle wounds. Diabet Foot Ankle. 2013 Sep 23;4.
  5. Strecker W., Fleischmann W. Nécroses cutanées traumatiques et non traumatiques. Pansements sous vide. Appareil Locomoteur. 2007:1-5. [Article 15-068-A-10]
  6. Mouës CM, Vos MC, van den Bemd GJ, Stijnen T, Hovius SE. Bacterial load in relation to vacuum-assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen. 2004;12(1):11-7.
  7. Leininger BE, Rasmussen TE, Smith DL, Jenkins DH, Coppola C. Experience with wound VAC and delayed primary closure of contaminated soft tissue injuries in Iraq. J Trauma. 2006;61(5):1207-11.
  8. Gregor S, Maegele M, Sauerland S, Krahn JF, Peinemann F, Lange S. Negative pressure wound therapy: a vacuum of evidence? Arch Surg. 2008;143(2):189-96.
  9. Scherer SS, Pietramaggiori G, Mathews JC, Prsa MJ, Huang S, Orgill DP. The mechanism of action of the vacuum-assisted closure device. Plast Reconstr Surg. 2008;122(3):786-97.
  10. Lee HJ, Kim JW, Oh CW, Min WK, Shon OJ, Oh JK, et al. Negative pressure wound therapy for soft tissue injuries around the foot and ankle. J Orthop Surg Res. 2009;4:14. 
  11. Argenta LC, Morykwas MJ, Marks MW, DeFranzo AJ, Molnar JA, David LR. Vacuum-assisted closure: state of clinic art. Plast Reconstr Surg. 2006;117(7 Suppl):127S-142S.
  12. Joseph E, Hamori CA, Bergman S, Roaf E, Swann NF, Anastasi GW. A prospective, randomized trial of vacuum-assisted closure versus standard therapy of chronic non-healing wounds. Wounds. 2000;12:60-7.